Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

RAP Femoral Venous Cannulae

K-Number: K250283 · 2025-07-10

Decision Date2025-07-10
Product CodeDWF
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

RAP Femoral Venous Cannulae is a medical device manufactured by LivaNova USA, Inc.. It received FDA 510(k) clearance on 2025-07-10 under approval number K250283. The device is classified under product code DWF. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the RAP Femoral Venous Cannulae?

RAP Femoral Venous Cannulae is a medical device that received FDA 510(k) clearance on 2025-07-10. It is manufactured by LivaNova USA, Inc.. The 510(k) number is K250283.

When was RAP Femoral Venous Cannulae approved by the FDA?

RAP Femoral Venous Cannulae received FDA 510(k) clearance on 2025-07-10, under approval number K250283.

What company makes RAP Femoral Venous Cannulae?

RAP Femoral Venous Cannulae is manufactured by LivaNova USA, Inc..

What is the FDA product code for RAP Femoral Venous Cannulae?

The FDA product code for RAP Femoral Venous Cannulae is DWF.

Related Clinical Trials

Other Devices by LivaNova USA, Inc.

Related Devices (Code: DWF)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.